The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution
Chuanxi Zheng,* Yong Zhou,* Yitian Wang, Yi Luo, Chongqi Tu, Li Min Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China*These authors contributed equally to this workCorrespondence: Li MinDepartment of Orthopedics, West Ch...
Saved in:
Main Authors: | Zheng C (Author), Zhou Y (Author), Wang Y (Author), Luo Y (Author), Tu C (Author), Min L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgery combined with anlotinib for local control of patients with resectable extremity desmoid fibromatosis: a retrospective study
by: Dechao Yuan, et al.
Published: (2024) -
FIBROMATOSIS (DESMOID TUMOR) OF THE BREAST. Fibromatosis (tumor desmoide) de mama
by: Zhaneta P Boceska, et al.
Published: (2016) -
Giant desmoid fibromatosis of the pancreas
by: Jeng-Chang Chen, et al.
Published: (2023) -
Giant abdominal desmoid-type fibromatosis
by: Saikat Mitra, et al.
Published: (2024) -
Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis
by: Luting Zhou, et al.
Published: (2019)